BIOMAT Database Logo BIOMAT Database Logo

Discovery of Dihydro-1,4-Benzoxazine Carboxamides as Potent and Highly Selective Inhibitors of Sirtuin-1. 2021

Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, Dortmund 44227, Germany.

Sirtuins are signaling hubs orchestrating the cellular response to various stressors with roles in all major civilization diseases. Sirtuins remove acyl groups from lysine residues of proteins, thereby controlling their activity, turnover, and localization. The seven human sirtuins, SirT1-7, are closely related in structure, hindering the development of specific inhibitors. Screening 170,000 compounds, we identify and optimize SirT1-specific benzoxazine inhibitors, Sosbo, which rival the efficiency and surpass the selectivity of selisistat (EX527). The compounds inhibit the deacetylation of p53 in cultured cells, demonstrating their ability to permeate biological membranes. Kinetic analysis of inhibition and docking studies reveal that the inhibitors bind to a complex of SirT1 and nicotinamide adenine dinucleotide, similar to selisistat. These new SirT1 inhibitors are valuable alternatives to selisistat in biochemical and cell biological studies. Their greater selectivity may allow the development of better targeted drugs to combat SirT1 activity in diseases such as cancer, Huntington's chorea, or anorexia.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009243 NAD A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) Coenzyme I,DPN,Diphosphopyridine Nucleotide,Nadide,Nicotinamide-Adenine Dinucleotide,Dihydronicotinamide Adenine Dinucleotide,NADH,Adenine Dinucleotide, Dihydronicotinamide,Dinucleotide, Dihydronicotinamide Adenine,Dinucleotide, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide,Nucleotide, Diphosphopyridine
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Discovery of 2,4-1H-Imidazole Carboxamides as Potent and Selective TAK1 Inhibitors.
April 2021, ACS medicinal chemistry letters,
Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors.
August 2018, ACS medicinal chemistry letters,
Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
9H-Carbazole-1-carboxamides as potent and selective JAK2 inhibitors.
July 2015, Bioorganic & medicinal chemistry letters,
Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1.
September 2023, Bioorganic chemistry,
Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors.
July 2018, Bioorganic & medicinal chemistry letters,
Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors.
February 2021, ACS medicinal chemistry letters,
Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Discovery of imidazole carboxamides as potent and selective CCK1R agonists.
August 2008, Bioorganic & medicinal chemistry letters,
Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.
September 2014, Bioorganic & medicinal chemistry,
Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.
November 2008, Journal of medicinal chemistry,
Martin Spinck, and Matthias Bischoff, and Philipp Lampe, and Franz-Josef Meyer-Almes, and Sonja Sievers, and Heinz Neumann
Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists.
May 2011, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!